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Introduction
Takayasu arteritis (TA) is a rare chronic inflammatory
disease of unknown origin mainly involving the large
vessels, such as the aorta and its primary branches.
There is no uniform strategy of therapy TA in children
owing to a rarity of this pathology and no specificity of
clinic.
Objectives
Efficacy of 3 treatment regiments (TR) was retrospec-
tively analysed in 38 children with TA aged from 3 till
16 years. Follow up period was 36 mo. In 27 of 38
patients diagnosis was established after a year from
emergence of the first symptoms and characterized by
widespread inflammation in the aorta and its main
branches.
Methods
Group 1 (36 patients) received the combined therapy by
glucocorticoids (Pr) and methotrexate (MTX). Cyclo-
phosphamide (CYC) used at 2 patients as first therapy
with widespread inflammation and in 6 – at inefficiency
of primary treatment of MTX (group 2). In 5 children
with refractory TA – infliximab (INF) (group 3). TR effi-
cacy was estimated by TA activity index (AI), based on
Birmingham scale of vasculitis activity (erythrocyte sedi-
mentation rate (ESR), C-reactive protein (CRP), clinical
symptoms and results of Doppler ultrasound, etc.).
Results
1 TR was effective in 67% patients, 2 TR show reliable
decrease in an index of activity in 6 months, remission is
noted in 12 months therapy. The success of 3 months INF
treatment was evaluated according to the normal signifi-
cances of ESR, CRP and lack of active disease symptoms,
after 6 months – reduced of vessel wall thickness.
Our data suggests that remission achieved in 32
patients (84%) within 2 years therapy. Full remission is
reached at all patients, the diagnosis by which about
6 months from an onset of the illness and at 65% with
diagnosis term were established more than 12 months.
Conclusion
At early diagnostics and the localized type of aorta
damage as starting basic therapy use of the combined
therapy Pr and MTX is expedient. At MTX inefficiency,
late diagnostics and widespread type of defeat of the
vascular course, vazorenal arterial hypertension - should
use CYC and INF.
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